Literature DB >> 21150207

Cardiomyocyte apoptosis after cardioplegic ischemia: comparison to unprotected regional ischemia-reperfusion.

M Malmberg1, J Parkka, T Vahasilta, A Saraste, T Laitio, J Kiss, J Latva-Hirvela, P Saukko, T Savunen.   

Abstract

BACKGROUND: Cardiomyocyte apoptosis might contribute to left ventricular (LV) dysfunction following cardiac surgery. Magnetic resonance imaging is considered the most accurate method of determining LV function. We compared apoptosis (by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling, TUNEL, staining and detection of caspase 3 activation) and LV function after regional ischemia-reperfusion (I-R) and global cardioplegic ischemia.
METHODS: Pigs were randomized to undergo regional myocardial I-R for 20 + 20 min, global myocardial ischemia with cardiopulmonary bypass (CPB) for 40 min or CPB without ischemia (control), followed by 274 min of reperfusion.
RESULTS: Compared with the control group, the number of TUNEL-positive cardiomyocytes was higher in the global ischemia group with CPB (0.024 ± 0.014%; p = 0.02) and further increased in areas of unprotected regional I-R (0.444 ± 0.562%; p = 0.003, vs. control). Myocytes with active caspase 3 were detected after global and regional ischemia. The global ejection fraction did not differ between CPB and regional I-R groups.
CONCLUSIONS: The use of cardioplegia and CPB efficiently protects the heart from global I-R-induced cardiomyocyte apoptosis during open heart surgery.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21150207     DOI: 10.1159/000321875

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  7 in total

1.  Integrated microRNA and mRNA responses to acute human left ventricular ischemia.

Authors:  Louis A Saddic; Tzuu-Wang Chang; Martin I Sigurdsson; Mahyar Heydarpour; Benjamin A Raby; Stanton K Shernan; Sary F Aranki; Simon C Body; Jochen D Muehlschlegel
Journal:  Physiol Genomics       Date:  2015-07-14       Impact factor: 3.107

2.  The altered expression profile of microRNAs in cardiopulmonary bypass canine models and the effects of mir-499 on myocardial ischemic reperfusion injury.

Authors:  Han Qin; Guang-xian Chen; Meng-ya Liang; Jian Rong; Jian-ping Yao; Hai Liu; Zhong-kai Wu
Journal:  J Transl Med       Date:  2013-06-21       Impact factor: 5.531

3.  Joint analysis of left ventricular expression and circulating plasma levels of Omentin after myocardial ischemia.

Authors:  Louis A Saddic; Sarah M Nicoloro; Olga T Gupta; Michael P Czech; Joshua Gorham; Stanton K Shernan; Christine E Seidman; Jon G Seidman; Sary F Aranki; Simon C Body; Timothy P Fitzgibbons; Jochen D Muehlschlegel
Journal:  Cardiovasc Diabetol       Date:  2017-07-07       Impact factor: 9.951

4.  Effect of limb ischemic preconditioning on myocardial apoptosis-related proteins in ischemia-reperfusion injury.

Authors:  Jianzhi Gao; Linjing Zhao; Yongling Wang; Qinglei Teng; Lidong Liang; Jinying Zhang
Journal:  Exp Ther Med       Date:  2013-02-26       Impact factor: 2.447

Review 5.  Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death.

Authors:  J Skommer; I Rana; F Z Marques; W Zhu; Z Du; F J Charchar
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

6.  Systemic Dosing of Thymosin Beta 4 before and after Ischemia Does Not Attenuate Global Myocardial Ischemia-Reperfusion Injury in Pigs.

Authors:  Christoffer K-J Stark; Miikka Tarkia; Rasmus Kentala; Markus Malmberg; Tommi Vähäsilta; Matti Savo; Ville-Veikko Hynninen; Mikko Helenius; Saku Ruohonen; Juho Jalkanen; Pekka Taimen; Tero-Pekka Alastalo; Antti Saraste; Juhani Knuuti; Timo Savunen; Juha Koskenvuo
Journal:  Front Pharmacol       Date:  2016-05-03       Impact factor: 5.810

7.  Anti-oxidative or anti-inflammatory additives reduce ischemia/reperfusions injury in an animal model of cardiopulmonary bypass.

Authors:  Aida Salameh; Stefan Dhein; Marie Mewes; Sophie Sigusch; Philipp Kiefer; Marcel Vollroth; Johannes Seeger; Ingo Dähnert
Journal:  Saudi J Biol Sci       Date:  2019-04-05       Impact factor: 4.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.